Skip to search formSkip to main contentSkip to account menu

FOLFOXIRI protocol

National Institutes of Health

Related topics

Related topics

6 relations

Broader (5)

Antineoplastic Combined Chemotherapy ProtocolsCamptothecinFluorouracilLeucovorin
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The role of FOLFOXIRI in chemorefractory metastatic colorectal cancer patients
2017
2017
Treatments (tx) after progression to first-line FOLFOXIRI plus bevacizumab (bev) in metastatic colorectal cancer (mCRC) patients (pts): A pooled analysis of TRIBE and MOMA studies by GONO group.
3542Background: FOLFOXIRI plus bev is regarded by international guidelines as a valuable option in the first-line tx of mCRC pts… 
2016
2016
TRIBE : la quadrithérapie FOLFOXIRI + bévacizumab, un nouveau standard en première ligne du cancer colorectal métastatique ?
Le groupe italien GONO avait montre voici bientot 10 ans, avant l’ere des therapies ciblees, la superiorite d’une… 
2013
2013
[Therapeutic strategy for recurrent gastric cancer and efforts aimed at finding a cure].
Recurrent gastric cancer, in general, is an incurable systemic disease for which the standard of care is systemic chemotherapy… 
2008
2008
Phase II study of first-line treatment in metastatic colorectal cancer (MCRC) with GONO-FOLFOXIRI (Irinotecan, Oxaliplatin and Infusional 5FU/LV) plus Bevacizumab
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)